Departments of 2 Pathology and 1 Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama 36688
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Activation of
Ca2+ entry is known to produce
endothelial cell shape change, leading to increased permeability,
leukocyte migration, and initiation of angiogenesis in conduit-vessel
endothelial cells. The mode of
Ca2+ entry regulating cell shape
is unknown. We hypothesized that activation of store-operated
Ca2+ channels (SOCs) is sufficient
to promote cell shape change necessary for these processes. SOC
activation in rat pulmonary arterial endothelial cells increased free
cytosolic Ca2+ that was dependent
on a membrane current having a net inward component of 5.45 ± 0.90 pA/pF at 80 mV. Changes in endothelial cell shape
accompanied SOC activation and were dependent on
Ca2+ entry-induced reconfiguration
of peripheral (cortical) filamentous actin (F-actin). Because the
identity of pulmonary endothelial SOCs is unknown, but mammalian
homologues of the Drosophila
melanogaster transient receptor potential
(trp) gene have been proposed to form Ca2+ entry channels in
nonexcitable cells, we performed RT-PCR using Trp oligonucleotide
primers in both rat and human pulmonary arterial endothelial cells.
Both cell types were found to express Trp1, but neither expressed Trp3
nor Trp6. Our study indicates that 1)
Ca2+ entry in pulmonary
endothelial cells through SOCs produces cell shape change that is
dependent on site-specific rearrangement of the microfilamentous
cytoskeleton and 2) Trp1 may be a
component of pulmonary endothelial SOCs.
lung; inflammation; permeability; F-actin; angiogenesis
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
PULMONARY ENDOTHELIAL CELLS are a nonexcitable cell type in which humoral and neural signaling agents increase the free cytosolic Ca2+ concentration ([Ca2+]i) by inducing Ca2+ release from intracellular stores and Ca2+ entry across the cell membrane (4, 34). Increased [Ca2+]i has been implicated in many endothelial-directed vascular responses including regulation of vascular tone and permeability (2, 23, 36), angiogenesis (20), and leukocyte trafficking (17). Activation of Ca2+ entry appears essential for each of these processes, although many modes of Ca2+ entry exist and a specific pathway regulating endothelial cell shape has yet to be identified.
It is widely accepted that endothelial cells possess capacitative, or
store-operated, Ca2+ entry
pathways (8, 13, 31, 35, 41, 42). However, specific store-operated
Ca2+ channels (SOCs) responsible
for Ca2+ entry into nonexcitable
cell types are largely unidentified. Recent cloning and expression of
the transient receptor potential (trp) gene product from the
Drosophila melanogaster retina reveal that this product forms a
Ca2+-permeant cation channel that
mediates Ca2+ entry after
intracellular inositol 1,4,5-trisphosphate
[Ins(1,4,5)P3] is generated and Ca2+ is liberated
from intracellular stores (11, 15, 25). Six mammalian homologues of
Drosophila Trp are known (5), and
mRNAs for these have been reported in bovine aortic endothelial cells (12). Although Trp3 and Trp6 are not SOCs (6, 46), Trp1 may form SOCs
based on the following experimental evidence:
1) Trp1 and its splice variant
TRPC1A increase store-operated
Ca2+ entry when expressed in COS
cells (45, 47) and 2) expression of
antisense trp sequences in murine
L(tk) cells greatly
attenuates store-operated Ca2+
entry evoked by Ins(1,4,5)P3 (45).
Information concerning putative functions for Trp2, -4, and -5 is
lacking in the literature.
Because activation of store-operated Ca2+ entry is known to increase vascular permeability in isolated lungs (9, 18), thereby suggesting that pulmonary endothelial SOCs are important for regulation of endothelial barrier integrity, we designed studies to characterize the store-operated Ca2+ entry pathway in rat (R) pulmonary arterial endothelial cells (PAECs). We hypothesized that a functional consequence of activating endothelial SOCs is a change in cell shape, leading to interendothelial gap formation and cytoskeletal rearrangement. To test this hypothesis, we challenged RPAECs with thapsigargin, a plant alkaloid that activates store-operated Ca2+ entry independent of ligand-receptor-G protein-coupled processes (40, 43), and monitored the changes in endothelial cell shape and microfilamentous cytoskeletal arrangement. We then determined whether RPAECs express Trp1 in order to address the possible molecular basis for the pulmonary endothelial store-operated Ca2+ entry pathway. Our data indicate that store-operated Ca2+ entry promotes cell shape change in rat pulmonary endothelial cells expressing Trp1 and further suggest that Ca2+ entry through SOCs involves site-specific rearrangement of the microfilamentous cytoskeleton.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Isolation of RPAECs. Male Sprague-Dawley rats (CD strain, 350-400 g; Charles River) were euthanized by an intraperitoneal injection of 50 mg of pentobarbital sodium (Nembutal, Abbott Laboratories, Chicago, IL). After sternotomy, the heart and lungs were removed en bloc, and the pulmonary arterial segment between the heart and lung hili was dissected, split, and fixed onto a 35-mm plastic dish. Endothelial cells were obtained by gentle intimal scraping with a plastic cell lifter and were seeded into a 100-mm petri dish containing 10 ml of seeding medium (~1:1 DMEM-Ham's F-12 + 10% fetal bovine serum) (37). After incubation for 1 wk (21% O2-5% CO2-74% N2 at 37°C), smooth muscle cell contaminants were marked and then removed by pipette aspiration. Cells were verified as endothelial by positive factor VIII staining and uptake of 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI)-labeled acetylated low-density lipoprotein. When the primary culture reached confluence, cells were passaged by trypsin digestion into T-75 culture flasks (Corning), and standard tissue culture techniques were followed until the cells were ready for experimentation ( passages 6-20).
[Ca2+]i measurement by fura 2 fluorescence. RPAECs were seeded onto chambered glass coverslips (Nalge Nunc, Naperville, IL) and grown to confluence. [Ca2+]i was estimated with the Ca2+-sensitive fluorophore fura 2-AM (Molecular Probes, Eugene, OR) according to methods previously described by our laboratory (38). Because this is the first report of [Ca2+]i measurements in cultured RPAECs, a summary of the technique will be presented. RPAECs were washed with 2 ml of a HEPES (Fisher Scientific, Atlanta, GA)-buffered physiological salt solution (PSS) containing (in g/l) 6.9 NaCl, 0.35 KCl, 0.16 KH2PO4, 0.141 MgSO4, 2.0 D-glucose, and 2.1 NaHCO3. The loading solution (1 ml) consisted of PSS plus 3 µM fura 2-AM, 3 µl of a 10% pluronic acid solution, and 2 mM or 100 nM CaCl2. RPAECs were fura loaded for 20 min in a CO2 incubator at 37°C. After this loading period, the cells were again washed with PSS (2 ml) and treated with deesterification medium (PSS + 2 mM or 100 nM CaCl2) for an additional 20 min. After deesterification, [Ca2+]i was assessed with an Olympus IX70 inverted microscope at ×400 with a xenon arc lamp photomultiplier system (Photon Technologies, Monmouth Junction, NJ), and data were acquired and analyzed with PTI Felix software. Epifluorescence (signal averaged) was measured from three to four endothelial cells in a confluent monolayer, and the changes in [Ca2+]i are expressed as the fluorescence ratio of the Ca2+-bound (340-nm) to Ca2+-unbound (380-nm) excitation wavelengths emitted at 510 nm.
Electrophysiological determination of store-operated
Ca2+ entry.
Whole cell patch clamp was utilized to measure transmembrane ion flux
in thapsigargin-stimulated RPAECs. Confluent RPAECs were enzyme
dispersed, seeded onto 35-mm plastic culture dishes, and then allowed
to reattach for at least 24 h before patch-clamp experiments were
performed. Single RPAECs exhibiting a flat, polyhedral morphology were
studied. These cells were chosen for study because their morphology was
consistent with RPAECs from a confluent monolayer. The extracellular
and pipette solutions were composed of the following (in mM):
1) extracellular: 110 tetraethylammonium aspartate, 10 calcium aspartate, 10 HEPES, and 0.5 3,4-diaminopyridine; and 2) pipette:
130 N-methyl-D-glucamine,
1.15 EGTA, 10 HEPES, 1 Ca(OH)2, and 2 Mg2+-ATP. Both solutions
were adjusted to 290-300 mosM with sucrose and pH 7.4 with methane
sulfonic acid, and
[Ca2+]i
was estimated as 100 nM (10). The pipette resistance was 2-5 M.
Data were obtained with a HEKA EPC9 amplifier (Lambrecht/Pfaltz) and
sampled on-line with Pulse + Pulsefit software (HEKA). All recordings
were made at room temperature (22°C). To generate current-voltage (I-V)
relationships, voltage pulses were applied from
100 to +100 mV
in 20-mV increments, with a 200-ms duration during each voltage step
and a 2-s interval between steps. The holding potential between each
step was 0 mV.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Thapsigargin activates store-operated Ca2+ entry in RPAECs. We monitored fura 2 epifluorescence, and as shown in Fig. 1A and summarized in Fig. 1C (open bars), RPAECs incubated in 2 mM [Ca2+]o had baseline fluorescence ratios averaging 0.91 ± 0.02. Thapsigargin produced a gradual increase in [Ca2+]i to a peak level followed by a modest decline, producing a new steady state, or plateau, in [Ca2+]i. Figure 1, B (dashed line) and C (solid bars), illustrates that the thapsigargin-induced response was dependent on [Ca2+]o. When experiments were repeated in PSS containing 100 nM [Ca2+]o, the baseline fluorescence ratio value decreased slightly, and both the peak and sustained plateau phases of the thapsigargin-induced response were significantly attenuated. Subsequent readdition of 2 mM [Ca2+]o produced an immediate increase in [Ca2+]i, thereby illustrating functional store-operated Ca2+ entry pathways.
|
|
Store-operated Ca2+ entry evokes endothelial cell shape change and F-actin cytoskeletal rearrangement in RPAECs. To determine a functional consequence of SOC activation in RPAECs, we assessed changes in endothelial cell shape and formation of intercellular gaps in thapsigargin-treated confluent RPAEC monolayers. Because we determined that SOC activation was apparent 3-5 min after thapsigargin treatment, we studied endothelial morphology at this fixed time point. Figure 3 shows scanning electron micrographs of RPAECs after different treatments. Untreated RPAECs (Fig. 3A) in 2 mM [Ca2+]o exhibited a characteristic "cobblestone" morphology essentially devoid of intercellular gaps. Thapsigargin produced endothelial cell retraction and intercellular gap formation (Fig. 3B). The changes in endothelial cell morphology were dependent on [Ca2+]o because RPAECs incubated in 100 nM [Ca2+]o and challenged with thapsigargin displayed little change in morphology and a lack of interendothelial gaps (Fig. 3C). The subsequent readdition of 2 mM [Ca2+]o had a dramatic effect on endothelial cell shape, causing pronounced cell retraction and gap formation (Fig. 3D). Thus Ca2+ entry through activated SOCs sufficiently promoted endothelial cell shape alterations and interendothelial gap formation.
|
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Although activation of Ca2+ entry is sufficient to induce the interendothelial cell gap formation necessary for the transit of macromolecules and cells from blood into tissue, the mode of Ca2+ entry responsible for changing cell shape is unknown. Nonexcitable cells possess store-operated Ca2+ entry pathways. Store-operated Ca2+ entry is activated in response to agonist-induced stimulation of membrane phospholipases, generation of Ins(1,4,5)P3, Ca2+ release from intracellular stores, and subsequent lowering of store Ca2+ concentrations (4, 8, 13, 16, 31, 34, 35, 41, 42). Presently, there are three prevailing questions regarding store-operated Ca2+ entry pathways. 1) What specific cellular functions are regulated by Ca2+ influx through this pathway? 2) What is the molecular identity of the membrane channels responsible for mediating store-operated Ca2+ entry? 3) What is the nature of the signal linking Ca2+ store depletion to store-operated Ca2+ entry? Our present study addressed the first two of these three important questions.
Thapsigargin was utilized to test store-operated Ca2+ entry pathways because this agent produces intracellular Ca2+ store depletion without the confounding influences of ligand-receptor-heterotrimeric G protein activation (40, 43, 47). Fura 2-loaded RPAEC monolayers exhibited an increased [Ca2+]i that was dependent on Ca2+ influx in response to thapsigargin, thereby indicating the presence of store-operated Ca2+ entry pathways. To begin elucidating the electrophysiological characteristics of RPAEC SOCs, we performed whole cell patch clamp in single cells. We designed intracellular and extracellular patch solutions to isolate thapsigargin-induced Ca2+ currents and determine whether thapsigargin activated a channel(s) responsible for Ca2+ release-activated current (ICRAC) (16). However, the thapsigargin-induced current measured under these experimental conditions was not identical to ICRAC because significant outward current was also measured.
It was possibile that the total current measured in response to
thapsigargin reflected coactivation of both a
Ca2+-selective cation channel and
an anion channel because aspartate was utilized to replace
Cl in the extracellular
solution, and aspartate has recently been shown to be conducted through
Ca2+- and/or
volume-activated Cl
channels(29). In support of this idea,
N-phenylanthranilic acid, a potent
blocker of Ca2+-activated anion
channels (27), had little effect on the inward current observed at
negative voltages but strongly attenuated the outward current at
positive voltages (data not shown). Thus thapsigargin may activate an
anion channel capable of conducting large organic anions as previously
reported in bovine pulmonary endothelium (27, 29). When the anion
conductance contribution to the total thapsigargin-stimulated current
is then considered, a current analogous to
ICRAC is
apparent. Future electrophysiological studies, including
ion-selectivity experiments and single-channel analysis, are necessary
to fully characterize the thapsigargin-sensitive Ca2+-permeable channels in RPAECs.
Activation of SOCs in RPAECs causes the appearance of intercellular gaps and rounding of endothelial cells. One intracellular target affected by SOC activation is plasmalemmal-associated and centrally located F-actin. It is accepted that changes in [Ca2+]i lead to reconfigurations of the microfilamentous cytoskeleton (21, 22, 30), although it has previously been unclear whether Ca2+ release from intracellular stores or Ca2+ influx is necessary to produce cytoskeletal changes leading to cell shape change.
Thapsigargin produced a loss of plasmalemmal F-actin staining concurrent with an increase in central F-actin staining. When store depletion alone was produced, i.e., thapsigargin in the absence of [Ca2+]o, rearrangement of cortical actin fibers did not occur and less F-actin staining was observed centrally. Under these conditions, RPAECs did not respond to thapsigargin with a change in cell shape. The readdition of [Ca2+]o caused morphological changes in both the peripheral (loss of dense actin staining) and centrally located (increased actin staining and transcellular filament formation) F-actin pools, indicating that Ca2+ influx through SOCs is sufficient to adjust the microfilament system of the cells to produce interendothelial gap formation. It is presently unclear how Ca2+ influx through SOCs specifically regulates the endothelial F-actin cytoskeleton, although a possible mediator of the Ca2+ influx-induced cytoskeletal rearrangement is Rho, a small-molecular-weight monomeric G protein, the activity of which produces actin polymerization and stress fiber formation (1, 14).
Interestingly, incubation of RPAEC monolayers in low [Ca2+]o alone caused rearrangement of central F-actin but had no apparent effect on peripheral, or cortical, F-actin. Under these conditions, Ca2+ release could have been promoted because a more favorable electrochemical gradient for Ca2+ to leak from intracellular stores existed. Centrally located F-actin in close proximity to Ca2+ stores could have been affected by Ca2+ release but not in a manner sufficient to drive an active cell shape change. We speculate that these observations may allude to the mechanism(s) leading to plasmalemmal SOC activation, i.e., through Ca2+ release-induced cytoskeletal rearrangement coupled to activation of plasmalemmal SOCs. Another possibility to consider with respect to the F-actin rearrangement is that low [Ca2+]o provided less basal Ca2+ influx that was somehow setting the F-actin cytoskeletal architecture. Future studies will be required to address this novel observation of the ability of [Ca2+]o to regulate the endothelial cytoskeleton and to specifically address whether F-actin is a vital component of the SOC activation mechanism.
Although our data clearly demonstrate that activation of SOCs regulate endothelial cell shape via effects on the microfilamentous cytoskeleton, we were unable to perform antagonist studies to specifically block SOC activation and the resulting cell shape change. This is because only nonspecific antagonists of endothelial Ca2+ entry pathways exist and the molecular identity of SOCs is unknown. In fact, the collective data from several previous studies (7, 24, 28, 31, 33, 35, 39, 41, 44) that investigated the nature of Ca2+ entry pathways in endothelial cells indicate that multiple SOCs and receptor-operated channels may exist, each having specific electrophysiological profiles and modes of optimal activation. We did, however, begin to deduce the identity of pulmonary endothelial SOCs using RT-PCR. Several trp gene products (Trp1 and Trp3-6) have recently been identified in systemic endothelial cells (12), and our findings indicate that at least Trp1, but neither Trp3 nor Trp6, is expressed in pulmonary endothelial cells. It is uncertain how trp gene products may be organized in the membrane to form a functional channel, but it has been proposed that SOCs may be composed of trp homo- and/or heteromultimers (5). Because our data indicate that neither Trp3 nor Trp6 are present in rat or human pulmonary endothelial cells, the SOC is not composed of Trp1-Trp3 or Trp1-Trp6 heteromultimers.
What are the implications of the observation that SOC activation produces changes in PAEC shape? It is possible that endothelial SOCs are integral for regulating pulmonary vascular permeability responses to inflammatory mediators. Whole lung studies (9, 18) have shown that activation of SOCs alone is sufficient to produce increased vascular permeability as assessed by measures of the filtration coefficient. In addition, SOC activation promotes increased flux of macromolecules across RPAEC monolayers (19, 26). However, stimulation of the thapsigargin-sensitive store-operated Ca2+ entry pathway in rat pulmonary microvascular endothelial cells promotes neither increased macromolecular permeability nor changes in cell shape (19). These observations suggest that inflammatory processes involving endothelial SOC activation can produce pulmonary edema mediated by the appearance of large-vessel leak sites away from the gas-exchanging microcirculatory bed. Therefore, future studies are needed to determine whether 1) pulmonary conduit-vessel endothelium and microvascular endothelium represent distinct phenotypes having separate regulatory properties, 2) changes in conduit-vessel endothelial cell shape in situ lead to significant, function-compromising pulmonary edema, 3) the precipitating factors for increasing large-vessel and small-vessel (capillary) permeabilities are the same, and 4) interventions to alleviate pulmonary edema can be designed to selectively target conduit-vessel endothelial cells vs. microvascular endothelial cells.
The shape change elicited in response to SOC activation in RPAECs has additional importance for other endothelial-directed physiological processes such as angiogenesis and regulation of leukocyte movement. The angiogenic process requires migration of endothelial cells that, in turn, is dependent on the ability of cells to change shape and decrease their cell-to-cell and cell-to-matrix tethering (3). Inhibition of non-voltage-gated Ca2+ channels, presumably including SOCs, inhibits angiogenic factor-induced proliferation, migration, and tube formation of human umbilical venous endothelial cells (20), which are endothelial cells derived from conduit vessels. In addition, a study (17) has shown that human umbilical venous endothelial cell-directed regulation of leukocyte trafficking is [Ca2+]i dependent. Changes in endothelial cell shape and tethering that accompany neutrophil adhesion and migration require increased [Ca2+]i. How the increased [Ca2+]i occurs is not clear, but a transmembrane Ca2+ flux is required for certain leukocyte secretory products to increase endothelial [Ca2+]i (32), thereby suggesting a role for SOC-mediated Ca2+ entry. Our data, in combination with these findings, suggest that initiation sites for angiogenesis and leukocyte diapedesis in vivo may be located in pulmonary vascular segments lined with endothelial cells possessing SOCs that regulate cell shape.
In summary, we have shown that RPAECs possess thapsigargin-activated SOCs that conduct current similar to ICRAC. RPAECs respond to this mode of Ca2+ entry with changes in cell shape, interendothelial gap formation, and rearrangement of the F-actin cytoskeleton. Cytoskeletal rearrangement may be differentially regulated by the extracellular and intracellular Ca2+ pools, with Ca2+ influx being necessary to produce a cytoskeleton configured for cell shape change. In addition, pulmonary endothelial cells from rats (and humans) express Trp1, which may be integral for forming native SOCs in these cell types. Finally, pulmonary conduit vessel-derived endothelial SOC activation leading to interendothelial gap formation may be the basis for some forms of pulmonary edema and/or a component of angiogenesis and regulation of leukocyte trafficking to and from the vasculature.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Natalie Norwood and Judy Creighton for excellent technical assistance and Drs. W. J. Thompson and Mark N. Gillespie for constructive advice.
![]() |
FOOTNOTES |
---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-56050 and HL-60024 (to T. Stevens); a Parker B. Francis Pulmonary Fellowship (to T. Stevens); and American Heart Association Alabama Affiliate Fellowships (to T. M. Moore and J. J. Kelly).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: T. M. Moore, Univ. of South Alabama, College of Medicine, Dept. of Pharmacology, MSB 3130, Mobile, AL 36688.
Received 13 February 1998; accepted in final form 14 May 1998.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Aepfelbacher, M.,
M. Essler,
E. Huber,
M. Sugai,
and
P. C. Weber.
Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells.
Arterioscler. Thromb. Vasc. Biol.
17:
1623-1629,
1997
2.
Barnes, P.,
and
S. Liu.
Regulation of pulmonary vascular tone.
Pharmacol. Rev.
47:
87-131,
1995[Medline].
3.
Beck, L. J.,
and
P. D'Amore.
Vascular development: cellular and molecular regulation.
FASEB J.
11:
365-373,
1997
4.
Berridge, M.
Elementary and global aspects of calcium signalling.
J. Physiol. (Lond.)
499:
291-306,
1997[Medline].
5.
Birnbaumer, L.,
X. Zhu,
M. Jiang,
G. Boulay,
M. Peyton,
B. Vannier,
D. Brown,
D. Platano,
H. Sadeghi,
E. Stefani,
and
M. Birnbaumer.
On the molecular basis and regulation of cellular capacitative calcium entry: roles for Trp proteins.
Proc. Natl. Acad. Sci. USA
93:
15195-15202,
1997
6.
Boulay, G.,
X. Zhu,
M. Peyton,
M. Jiang,
R. Hurst,
E. Stefani,
and
L. Birnbaumer.
Cloning and expression of a novel mammalian homolog of Drosophila transient receptor potential (Trp) involved in calcium entry secondary to activation of receptors coupled by the Gq class of G protein.
J. Biol. Chem.
272:
29672-29680,
1997
7.
Brauneis, U.,
Z. Gatmaitan,
and
I. Arias.
Serotonin stimulates a Ca2+ permeant nonspecific cation channel in hepatic endothelial cells.
Biochem. Biophys. Res. Commun.
186:
1560-1566,
1992[Medline].
8.
Cabello, O.,
and
W. Schilling.
Vectorial Ca2+ flux from the extracellular space to the endoplasmic reticulum via a restricted cytoplasmic compartment regulates inositol 1,4,5-trisphosphate-stimulated Ca2+ release from internal stores in vascular endothelial cells.
Biochem. J.
295:
357-366,
1993[Medline].
9.
Chetham, P.,
A. Guldemeester,
N. Mons,
G. Brough,
J. Bridges,
W. Thompson,
and
T. Stevens.
Ca2+-inhibitable adenylyl cyclase and pulmonary microvascular permeability.
Am. J. Physiol.
273 (Lung Cell. Mol. Physiol. 17):
L22-L30,
1997
10.
Fabiato, A.,
and
F. Fabiato.
Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells.
J. Physiol. Paris
75:
463-505,
1979[Medline].
11.
Friel, D.
TRP: its role in phototransduction and store-operated Ca2+ entry.
Cell
85:
617-619,
1996[Medline].
12.
Garcia, R. L.,
and
W. P. Schilling.
Differential expression of mammalian TRP homologues across tissues and cell lines.
Biochem. Biophys. Res. Commun.
239:
279-283,
1997[Medline].
13.
Gericke, M.,
G. Droogmans,
and
B. Nilius.
Thapsigargin discharges intracellular stores and induces transmembrane currents in human endothelial cells.
Pflügers Arch.
422:
552-557,
1993[Medline].
14.
Hall, A.
Rho GTPases and the actin cytoskeleton.
Science
279:
509-514,
1998
15.
Hardie, R.,
and
B. Minke.
The trp gene is essential for a light-activated Ca2+ channel in Drosophila photoreceptors.
Neuron
8:
643-651,
1992[Medline].
16.
Hoth, M.,
and
R. Penner.
Depletion of intracellular calcium stores activates a calcium current in mast cells.
Nature
355:
353-356,
1992[Medline].
17.
Huang, A.,
J. Manning,
T. Bandak,
M. Ratau,
K. Hanser,
and
S. Silverstein.
Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells.
J. Cell Biol.
120:
1371-1380,
1993[Abstract].
18.
Ivey, C. L.,
and
M. I. Townsley.
The effects of thapsigargin on pulmonary vasculature in canine pacing-induced heart failure (Abstract).
Microcirculation
4:
A170,
1997.
19.
Kelly, J. J.,
T. M. Moore,
P. Babal,
A. H. Diwan,
T. Stevens,
and
W. J. Thompson.
Pulmonary microvascular and macrovascular endothelial cells: differential regulation of calcium and permeability.
Am. J. Physiol.
274 (Lung Cell. Mol. Physiol. 18):
L810-L819,
1998
20.
Kohn, E.,
R. Alessandro,
J. Spoonster,
R. Wersto,
and
L. Liotta.
Angiogenesis: role of calcium-mediated signal transduction.
Proc. Natl. Acad. Sci. USA
92:
1307-1311,
1995[Abstract].
21.
Kuhne, W.,
M. Besselmann,
T. Noll,
A. Muhs,
H. Watanabe,
and
H. Piper.
Disintegration of cytoskeletal structure of actin filaments in energy-depleted endothelial cells.
Am. J. Physiol.
264 (Heart Circ. Physiol. 33):
H1599-H1608,
1993
22.
Lum, H.,
J. L. Aschner,
P. G. Phillips,
P. W. Fletcher,
and
A. B. Malik.
Time course of thrombin-induced increase in endothelial permeability: relationship to Ca2+i and inositol polyphosphates.
Am. J. Physiol.
263 (Lung Cell. Mol. Physiol. 7):
L219-L225,
1992
23.
Lum, H.,
and
A. Malik.
Regulation of vascular endothelial barrier function.
Am. J. Physiol.
267 (Lung Cell. Mol. Physiol. 11):
L223-L241,
1994
24.
Mendelowitz, D.,
K. Bacal,
and
D. Kunze.
Bradykinin-activated calcium influx pathway in bovine aortic endothelial cells.
Am. J. Physiol.
262 (Heart Circ. Physiol. 31):
H942-H948,
1992
25.
Montell, C.,
and
G. Rubin.
Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction.
Neuron
2:
1313-1323,
1989[Medline].
26.
Moore, T. M., G. Brough, J. J. Kelly, P. Babal, and T. Stevens. Regulation of pulmonary endothelial cell
shape by Trp-mediated calcium entry (Abstract).
Chest. In press.
27.
Nilius, B.,
J. Prenen,
G. Szucs,
L. Wei,
F. Tanzi,
T. Voets,
and
G. Droogmans.
Calcium-activated chloride channels in bovine pulmonary artery endothelial cells.
J. Physiol. (Lond.)
498:
381-396,
1997[Abstract].
28.
Nilius, B.,
G. Schwartz,
M. Oike,
and
G. Droogmans.
Histamine-activated, non-selective cation currents and Ca2+ transients in endothelial cells from human umbilical vein.
Pflügers Arch.
424:
285-293,
1993[Medline].
29.
Nilius, B.,
G. Szucs,
S. Heinke,
T. Voets,
and
G. Droogmans.
Multiple types of chloride channels in bovine pulmonary artery endothelial cells.
J. Vasc. Res.
34:
220-228,
1997[Medline].
30.
Northover, A.
In vitro effects of PAF on venous endothelial cell actin disposition.
Agents Actions
35:
40-49,
1992[Medline].
31.
Pasyk, E.,
M. Inazu,
and
E. Daniel.
CPA enhances Ca2+ entry in cultured bovine pulmonary artery endothelial cells in an IP3-independent manner.
Am. J. Physiol.
268 (Heart Circ. Physiol. 37):
H138-H146,
1995
32.
Peterson, M.,
D. Gruenhaupt,
and
D. Shasby.
Neutrophil cathepsin G increases calcium flux and inositol polyphosphate production in cultured endothelial cells.
J. Immunol.
143:
609-616,
1989
33.
Popp, R.,
and
H. Gogelein.
A calcium and ATP sensitive nonselective cation channel in the antiluminal membrane of rat cerebral capillary endothelial cells.
Biochim. Biophys. Acta
1108:
59-66,
1992[Medline].
34.
Putney, J.,
and
G. Bird.
The inositol phosphate-calcium signaling system in non-excitable cells.
Endocr. Rev.
14:
610-631,
1993[Medline].
35.
Schilling, W.,
O. Cabello,
and
L. Rajan.
Depletion of the inositol 1,4,5-trisphosphate-sensitive intracellular Ca2+ store in vascular endothelial cells activates the agonist-sensitive Ca2+-influx pathway.
Biochem. J.
284:
521-530,
1992[Medline].
36.
Shasby, D.,
and
S. Shasby.
Effects of calcium on transendothelial albumin transfer and electrical resistance.
J. Appl. Physiol.
60:
71-79,
1986
37.
Stevens, T.,
G. Brough,
T. Moore,
P. Babal,
and
W. Thompson.
Endothelial cells.
In: Methods in Pulmonary Research, edited by S. Uhlis,
and A. E. Taylor. Basel: Birkhauser Verlag, 1997, p. 403-428.
38.
Stevens, T.,
Y. Nakahashi,
D. Cornfield,
I. McMurtry,
D. Cooper,
and
D. Rodman.
Calcium inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function.
Proc. Natl. Acad. Sci. USA
92:
2696-2700,
1995[Abstract].
39.
Takeda, K.,
and
M. Klepper.
Voltage-dependent and agonist-activated ionic currents in vascular endothelial cells: a review.
Blood Vessels
27:
169-183,
1990[Medline].
40.
Thastrup, O.,
P. Cullen,
B. Drobak,
M. Hanley,
A. Dawson,
and
B. Drbak.
Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+ ATPase.
Proc. Natl. Acad. Sci. USA
87:
2466-2470,
1990[Abstract].
41.
Vaca, L.,
and
D. Kunze.
Depletion and refilling of intracellular Ca2+ stores induce oscillations of Ca2+ current.
Am. J. Physiol.
264 (Heart Circ. Physiol. 33):
H1319-H1322,
1993
42.
Vaca, L.,
and
D. Kunze.
Depletion of intracellular Ca2+ stores activates a Ca2+-selective channel in vascular endothelium.
Am. J. Physiol.
267 (Cell Physiol. 36):
C920-C925,
1994
43.
Vaca, L.,
W. Sinkins,
Y. Hu,
D. Kunze,
and
W. Schilling.
Activation of recombinant trp by thapsigargin in Sf9 insect cells.
Am. J. Physiol.
267 (Cell Physiol. 36):
C1501-C1505,
1994
44.
Ying, X.,
Y. Minamiya,
C. Fu,
and
J. Bhattacharya.
Ca2+ waves in lung capillary endothelium.
Circ. Res.
79:
898-908,
1996
45.
Zhu, X.,
M. Jiang,
M. Peyton,
G. Boulay,
R. Hurst,
E. Stefani,
and
L. Birnbaumer.
trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry.
Cell
85:
661-671,
1996[Medline].
46.
Zitt, C.,
A. G. Obukhov,
C. Strubing,
A. Zobel,
F. Kalkbrenner,
A. Luckhoff,
and
G. Schultz.
Expression of TRPC3 in Chinese hamster ovary cells results in calcium-activated cation currents not related to store depletion.
J. Cell Biol.
138:
1333-1341,
1997
47.
Zitt, C.,
A. Zobel,
A. Obukhov,
C. Harteneck,
F. Kalkbrenner,
A. Luckhoff,
and
G. Schultz.
Cloning and functional expression of a human Ca2+-permeable cation channel activated by calcium store depletion.
Neuron
16:
1189-1196,
1996[Medline].